Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 8-K Event Other events
  2. 4 Open-market sale Chief Financial Officer sold 295 shares at $158.50 ($46,758)
  3. 8-K Event Other events
  4. 4 Open-market sale Global Head of R&D sold 458 shares at $177.32 ($81,215)
  5. 4 Grant or award Chief Executive Officer acquired 334,009 shares (grant or award)
  6. 4 Grant or award Global Head of R&D acquired 125,255 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 104,377 shares (grant or award)
  8. 4 Grant or award President, COO & GM China acquired 187,876 shares (grant or award)
  9. 4 Grant or award Director acquired 16,692 shares (grant or award)
  10. 4 Grant or award Director acquired 83,499 shares (grant or award)
  11. 4 Grant or award Director acquired 16,692 shares (grant or award)
  12. 4 Grant or award Director acquired 16,692 shares (grant or award)
  13. 4 Grant or award Director acquired 16,692 shares (grant or award)
  14. 4 Grant or award Director acquired 16,692 shares (grant or award)
  15. 4 Grant or award Director acquired 16,692 shares (grant or award)
  16. 4 Grant or award Director acquired 66,768 shares (grant or award)
  17. 4 Grant or award Director acquired 16,692 shares (grant or award)
  18. 4 Open-market sale Global Head of R&D sold 1,168 shares at an average $145.35 ($169,767)
  19. 4 Open-market sale President, COO & GM China sold 1,588 shares at an average $142.63 ($226,495)
  20. 8-K Event Executive or director change · Shareholder vote results · Other events

Page 29 of 64 · 1,278 filings